findmyKOL
Clinical trialNCT06175208Enrolling, by, invitationInterventional

Targeting Fear of Cancer Recurrence in Cancer Survivors: Evaluation of Internet-Based Emotional Freedom Techniques and Internet-Based Mindfulness Meditation as Intervention Strategies

SponsorGeneral Hospital GroeningeEnrollment339Fear of Cancer Recurrence
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Philip R Debruyne, MD, PhD

    Kortrijk Cancer Centre,General Hospital Groeninge

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Az Klina

    Brasschaat, Antwerp, Belgium

  • University Hospital Antwerp

    Edegem, Antwerp, Belgium

  • University Hospital Gent

    Ghent, East-Flanders, Belgium

  • University Hospital Leuven

    Leuven, Vlaams-Brabant, Belgium

  • Kortrijk Cancer Centre, Az Groeninge

    Kortrijk, West-Flanders, Belgium

  • Imelda Ziekenhuis

    Bonheiden, Belgium

  • Jessa Ziekenhuis

    Hasselt, Belgium

  • University Hospital Brussels

    Jette, Belgium

  • Az Glorieux

    Ronse, Belgium

  • Vitaz

    Sint-Niklaas, Belgium

  • Az Vesalius

    Tongeren, Belgium

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 Jul 2024
Primary completion
1 Aug 2028
Completion
30 Oct 2028
Last update posted
26 Jul 2024
Registered enrollment
339
Registry id
NCT06175208

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.